The study of effects of “Chondrolife” combined cream-gel in the spontaneous pain sensitivity experiment
DOI:
https://doi.org/10.24959/cphj.16.1394Keywords:
osteoarthritis, glucosamine, chondroitine, topical drugs, pain, analgesimetryAbstract
The leading areas of pathogenetic treatment of osteoarthritis include: modulation of inflammation, regulation of metabolism and stimulation of chondrocytes of cartilage synthesis. [6] Reduction of pain - another no less important aspect of treatment [7]. Today, along with the regular use of drugs in the treatment of articular syndrome in osteoarthritis focuses on local therapy, including the use of ointments and gels. [15] The aim of this study was to study the analgesic action of the original cream-gel codenamed "Chondrolife" containing glucosamine hydrochloride, chondroitin sulfate, camphor and menthol. Antinociceptive effect of cream gel "Chondrolife" compared to reference drugs "Chondroxide®" gel and "Fastum gel" studied at cutaneous application on the model karahenin-induced acute gonarthritis in rats by impact to the severity of spontaneous pain using an Incapacitance Tester MkV („Linton Instrumentation”, Great Britain). Cream-gel "Chondrolife " showed significantly better antinociceptive effect compared to the reference drug "Chondroxide®" gel and not inferior antinociceptive activity "Fastum gel" on the 6th hour (in 1 hour after drugs application) and, although the seventh hour activity (in 2 hours after drugs application) of cream-gel " Chondrolife " gradually reduced and slightly inferior activity "Fastum gel", it is likely higher than the gel " Chondroxide®" that gives reason to continue study of combined cream-gel " Chondrolife" as chondroprotective analgesic agent and local use.References
Балабанова Р. М. Динамика распространенности ревматических заболеваний, входящих в XIII класс МКБ-10, в популяции взрослого населения Российской Федерации за 2000–2010 гг. / Р.М. Балабанова, Ш. Ф. Эрдес // Научно-практическая ревматология. – 2012. – № 3. – С. 10–12.
Доклинические исследования лекарственных средств : метод. рек. / под ред. А.В. Стефанова. – К: Авиценна, 2002. – 528 с.
Зупанец И.А., Зимин С.М. Анализ эффективности оригинального комбинированного хондропротектора на модели системного стероидного артроза у крыс/ European Applied Sciences. - 2013, 10 (1). - Р. 58-61.
Науково-практичні рекомендації з утримання лабораторних тварин та роботи з ними / Ю. М. Кожем’якін, О. С. Хромов, М. А. Філоненко, Г. А. Сайфетдінова. – К.: Державний фармакологічний центр МОЗ України, 2002. – 155 с.
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) / O. Bruyère, C. Cooper, J. P. Pelletier [et al.] // Semin. Arthritis Rheum. – 2014. – Vol. 44, № 3. – P. 253-263.
EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis / W. Zhang, M. Doherty, G. Peat [et al.] // Ann. Rheum. Dis. – 2010. – Vol. 69, № 3. – P. 483–489.
EULAR Textbook on Rheumatic Diseases / Editor Johannes W. J. Bijlsma // Osteoarthritis treatment. – 2012. – P. 749–768.
European convention for the protection of vertebrate animals used for experimental and other scientific purpose : Council of Europe. – Strasbourg, 1986. – 52 p.
Harirforoosh S. Adverse Effects of Nonsteroidal Antiinflammatory Drugs: An Update of Gastrointestinal, Cardiovascular and Renal Complications / S. Harirforoosh, W. Asghar, F. Jamali // J. Pharm. Sci. – 2013. – Vol. 16, № 5. – P. 821–847.
Hrnack S. A. Managing the pain of knee osteoarthritis / S. A. Hrnack, F. A. Barber // Phys. Sportsmed. – 2015. – Vol. 42, № 3. – P. 63-70.
MOST and OAI investigators. Physical activity, alignment and knee osteoarthritis: data from MOST and the OAI // D. T. Felson, J. Niu, T. Yang [et al.] // Osteoarthritis Cartilage. – 2013. – Vol. 21, № 6. – P. 789–795.
New findings in osteoarthritis pathogenesis: therapeutic implications // L. Pulsatelli, O. Addimanda, V. Brusi [et al.] // Ther. Adv. Chronic Dis. – 2013. – Vol. 10, № 1. – P. 23-43.
OARSI guidelines for the non-surgical management of knee osteoarthritis / T. E. McAlindon, R. R. Bannuru, M. C. Sullivan [et al.] // Osteoarthritis and Cartilage. – 2014. – Vol. 22, № 3. – P. 363–388.
Peniston J. H. An open–label, long–term safety and tolerability trial of diclofenac sodium 1% gel in patients with knee osteoarthritis / J. H. Peniston, M. S. Gold, L. K. Alwine // Phys. Sportsmed. – 2011. – Vol. 39, № 3. – P. 31–38.
Prevention of Knee Osteoarthritis in Overweight Females: The First Preventive Randomized Controlled Trial in Osteoarthritis / J. Runhaar, M. van Middelkoop, M. Reijman [et al.] // Am. J. Med. – 2015. – Vol. 128, № 8. – P. 888-895.
Downloads
Published
Issue
Section
License
Copyright (c) 2016 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
